---
title: "Cofco Biotechnology Co., Ltd. (000930.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/000930.SZ.md"
symbol: "000930.SZ"
name: "Cofco Biotechnology Co., Ltd."
industry: "Specialty Chemicals"
datetime: "2026-05-20T19:30:12.393Z"
locales:
  - [en](https://longbridge.com/en/quote/000930.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/000930.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/000930.SZ.md)
---

# Cofco Biotechnology Co., Ltd. (000930.SZ)

## Company Overview

COFCO Biotechnology Co., Ltd., together with its subsidiaries, engages in the processing and production of biochemical products in China. The company offers edible corn, special, waxy corn, and modified waxy corn starch; feed products, such as corn gluten meal, sprayed corn husk, corn germ meal, DDGS, fertilizer raw materials and glutamic acid residue; sweeteners comprising special syrup for frozen dough, compound fructose powder, maltodextrin, and fructose and glucose syrups; edible alcohol and fuel ethanol; and monosodium glutamate, anhydrous citric acid, potassium citrate, polylactic acid, phytosterols, and natural vitamin E. The company was formerly known as COFCO Biochemical (Anhui) Co., Ltd. and changed its name to COFCO Biotechnology Co., Ltd.

| Item | Detail |
|------|--------|
| Industry | Specialty Chemicals |
| Exchange | CN Market |
| Website | [www.cofcotech.com](https://www.cofcotech.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:11.000Z

**Overall: C (0.60)**

**Industry**: Specialty Chemicals

| Metric | Value |
|--------|-------|
| Industry Ranking | 67 / 154 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -13.71% |  |
| Net Profit YoY | -402.80% |  |
| P/B Ratio | 0.97 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 10154204753.38 |  |
| Revenue | 17035538107.34 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -1.18% | D |
| Profit Margin | -0.73% | D |
| Gross Margin | 5.71% | E |
| Revenue YoY | -13.71% | E |
| Net Profit YoY | -402.80% | E |
| Total Assets YoY | -0.91% | D |
| Net Assets YoY | -1.53% | D |
| Cash Flow Margin | -948.14% | E |
| OCF YoY | -13.71% | E |
| Turnover | 0.96 | A |
| Gearing Ratio | 38.82% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Cofco Biotechnology Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-13.71%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-402.80%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "0.97",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "10154204753.38",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "17035538107.34",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-1.18%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-0.73%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "5.71%",
          "rating": "E"
        },
        {
          "name": "Revenue YoY",
          "value": "-13.71%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "-402.80%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-0.91%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-1.53%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-948.14%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "-13.71%",
          "rating": "E"
        },
        {
          "name": "Turnover",
          "value": "0.96",
          "rating": "A"
        },
        {
          "name": "Gearing Ratio",
          "value": "38.82%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -80.20 | 145/154 | 252.39 | 141.32 | 116.82 |
| PB | 0.95 | 2/154 | 1.13 | 1.05 | 1.01 |
| PS (TTM) | 0.58 | 1/154 | 0.66 | 0.60 | 0.57 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | wanhua (600309.SH) | B | B | B | D | A | B |
| 02 | Ganfeng Lithium (002460.SZ) | B | A | D | C | B | B |
| 03 | NHU (002001.SZ) | A | C | C | B | C | B |
| 04 | DING LONG (300054.SZ) | A | B | C | C | B | B |
| 05 | FEILIHUA (300395.SZ) | B | A | D | A | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-01-07T16:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 5.34 |
| Highest Target | 6.80 |
| Lowest Target | 6.80 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/000930.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/000930.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/000930.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/000930.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**